The imbalance in immune cells contributes to the persistent secretion of pro‐inflammatory cytokines, such as MCP‐1, IL‐6, and TNF‐α, which induces insulin resistance and dyslipidemia [30, 31]. Here, CCL2 is linked to metabolic syndrome.